In August 2019, the American Academy of Pediatrics published a new clinical report, "Management of Infants at Risk for Group B Streptococcal Disease." This report details acceptable management approaches to assessing risk of neonatal GBS disease and replaces prior guidance published by CDC.
Terms of use
The User acknowledges and agrees that this tool will be used only as a reference aid, and that the information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
In view of the possibility of human error or changes in medical science, the User should confirm the information in the product conforms to the current version of the CDC GBS guidelines by checking for guideline updates. This product is provided without warranties of any kind, express or implied, and the authors disclaim any liability, loss, or damage caused by it or its content.
By indicating ‘I agree’ below, you have indicated your acceptance of these terms.
Disclaimers: This tool is based on the 2010 CDC GBS guidelines and is provided as a reference aid. Please check current guidelines updates. The information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
Disclaimers: This tool is based on the 2010 CDC GBS guidelines and is provided as a reference aid. Please check current guidelines updates. The information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
Disclaimers: This tool is based on the 2010 CDC GBS guidelines and is provided as a reference aid. Please check current guidelines updates. The information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
Disclaimers: This tool is based on the 2010 CDC GBS guidelines and is provided as a reference aid. Please check current guidelines updates. The information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
Disclaimers: This tool is based on the 2010 CDC GBS guidelines and is provided as a reference aid. Please check current guidelines updates. The information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
Disclaimers: This tool is based on the 2010 CDC GBS guidelines and is provided as a reference aid. Please check current guidelines updates. The information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
Disclaimers: This tool is based on the 2010 CDC GBS guidelines and is provided as a reference aid. Please check current guidelines updates. The information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
Disclaimers: This tool is based on the 2010 CDC GBS guidelines and is provided as a reference aid. Please check current guidelines updates. The information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
Disclaimers: This tool is based on the 2010 CDC GBS guidelines and is provided as a reference aid. Please check current guidelines updates. The information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.
*
If ANY signs or symptoms of sepsis develop, antibiotic therapy should be initiated and a full diagnostic evaluation, consisting of: a blood culture, complete blood count (CBC), including white cell differential and platelet count, a chest radiograph (if respiratory abnormalities are present), and a lumbar puncture (if patient is stable enough to tolerate procedure) should be conducted.
Antibiotic therapy should be directed toward most common causes of neonatal sepsis, including ampicillin for GBS and coverage for other organisms (including Escherichia coli and other gram-negative pathogens) should take into account local antibiotic resistance patterns.
Disclaimers: This tool is based on the 2010 CDC GBS guidelines and is provided as a reference aid. Please check current guidelines updates. The information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgment.